ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 48 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $8,127 | -54.8% | 21,905 | -40.1% | 0.00% | – |
Q3 2022 | $18,000 | +50.0% | 36,591 | +82.6% | 0.00% | – |
Q2 2022 | $12,000 | -98.3% | 20,035 | -96.3% | 0.00% | -100.0% |
Q4 2021 | $716,000 | +400.7% | 542,212 | +2654.7% | 0.00% | – |
Q1 2021 | $143,000 | -64.8% | 19,683 | -79.0% | 0.00% | -100.0% |
Q4 2020 | $406,000 | -7.1% | 93,932 | +29.1% | 0.00% | -50.0% |
Q2 2020 | $437,000 | +9.5% | 72,752 | +37.2% | 0.00% | -33.3% |
Q1 2020 | $399,000 | +33.9% | 53,015 | +144.5% | 0.00% | +200.0% |
Q4 2019 | $298,000 | – | 21,687 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |